¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"B cell study"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
asexual cell
¹«¼º¼¼Æ÷
acidophilic cell
È£»ê¼¼Æ÷
acinar cell
»ù²Ê¸®¼¼Æ÷, ¼¼¿±¼¼Æ÷
acinar cell carcinoma
»ù²Ê¸®¼¼Æ÷¾ÏÁ¾, ¼¼¿±¼¼Æ÷¾ÏÁ¾
acinic cell carcinoma
»ù²Ê¸®¼¼Æ÷¾ÏÁ¾, ¼¼¿±¼¼Æ÷¾ÏÁ¾
adult T-cell leukemia/lymphoma
¼ºÀÎT¼¼Æ÷¹éÇ÷º´/¸²ÇÁÁ¾
amacrine cell
¹«Ãà»è¼¼Æ÷
ameboid cell
¾Æ¸Þ¹Ù¸ð¾ç¼¼Æ÷
anaplastic large cell lymphoma
¿ªÇü¼ºÅ«¼¼Æ÷¸²ÇÁÁ¾
basal cell
¹Ù´Ú¼¼Æ÷, ±âÀú¼¼Æ÷
basal cell adenoma
¹Ù´Ú¼¼Æ÷»ùÁ¾, ±âÀú¼¼Æ÷¼±Á¾
basal cell carcinoma
¹Ù´Ú¼¼Æ÷¾ÏÁ¾, ±âÀú¼¼Æ÷¾ÏÁ¾
basal cell epithelioma
¹Ù´Ú¼¼Æ÷»óÇÇÁ¾, ±âÀú¼¼Æ÷»óÇÇÁ¾
basal cell nevus
¹Ù´Ú¼¼Æ÷¸ð¹Ý, ±âÀú¼¼Æ÷¸ð¹Ý
basal cell nevus syndrome
¹Ù´Ú¼¼Æ÷¸ð¹ÝÁõÈıº, ±âÀú¼¼Æ÷¸ð¹ÝÁõÈıº
ÀÌÀü
´ÙÀ½
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
plasma cell
ÇüÁú¼¼Æ÷
polynucleated cell
¹µÇÙ¼¼Æ÷
prickle cell
°¡½Ã¼¼Æ÷
principal cell
ÁÖ¼¼Æ÷, À¸¶ä¼¼Æ÷
Purkinje cell
1. ½ÉÀåÀüµµ±ÙÀ°¼¼Æ÷, 2. Á¶·Õ¹Ú¼¼Æ÷
pyramidal cell
ÇǶó¹Ìµå¼¼Æ÷
red blood cell
ÀûÇ÷±¸
reserve cell
¿¹ºñ¼¼Æ÷
resting cell
ÈÞÁö±â¼¼Æ÷, Á¤Áö¼¼Æ÷
reticuloendothelial cell
±×¹°³»ÇǼ¼Æ÷, ¼¼¸Á³»ÇǼ¼Æ÷
rod cell
¸·´ë¼¼Æ÷
round cell
¿øÇü¼¼Æ÷
satellite cell
À§¼º¼¼Æ÷
scavenger cell
û¼Ò¼¼Æ÷
Schwann's cell
½Å°æÁý¼¼Æ÷
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
acantholytic cell
°¡½Ã¼¼Æ÷ÇØ¸®¼¼Æ÷
accessory cell
º¸Á¶¼¼Æ÷, µ¡¼¼Æ÷
acidophilic cell
È£»ê¼º¼¼Æ÷
acinar cell
»ù²Ê¸®¼¼Æ÷
acinic cell carcinoma
»ù²Ê¸®¼¼Æ÷¾ÏÁ¾, ¼¼¿±¼¼Æ÷¾ÏÁ¾
amacrine cell
¹«Ãà»è¼¼Æ÷
ameboid cell
¾Æ¸Þ¹Ù¸ð¾ç¼¼Æ÷
annular elastotic giant cell granuloma
°í¸®Åº·Â¼¶À¯°Å´ë¼¼Æ÷À°¾ÆÁ¾, ȯ»óź·Â¼¶À¯°Å´ë¼¼Æ÷À°¾ÆÁ¾
antibody-dependent cell-mediated cytotoxicity
Ç×üÀÇÁ¸¼¼Æ÷¸Å°³¼¼Æ÷µ¶¼º
antibody-producing cell
Ç×ü»ý»ê¼¼Æ÷
antibody-screening cell
Ç×ü¼±º°Ç÷±¸
antigen-presenting cell
Ç׿øÀü´Þ¼¼Æ÷
antigen-reactive cell
Ç׿ø¹ÝÀÀ¼¼Æ÷
antigen-recognizing cell
Ç׿øÀÎÁö¼¼Æ÷
argentaffin cell
ģũ·ÒÀº¼¼Æ÷
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
LE cell phenomenon
LE¼¼Æ÷Çö»ó.
Langerhans cell
¶û°Ô¸£Çѽº¼¼Æ÷.
Langerhans cell histiocytosis
¶û°Ô¸£Çѽº ¼¼Æ÷ Á¶Á÷±¸Áõ
Langerhans cell histiocytosis
¶û°Ô¸£Çѽº¼¼Æ÷Á¶Á÷±¸Áõ
Langerhans giant cell
¶û±×Çѽº°Å¼¼Æ÷
Langhans giant cell
¶û±×Çѽº°Å´ë¼¼Æ÷
Leydig cell
·¹À̵ðÈ÷ ¼¼Æ÷
Leydig cell adenoma
·¹À̵ðÈ÷¼¼Æ÷¼±Á¾
Leydig cell tumor
·¹À̵ðÈ÷¼¼Æ÷Á¾¾ç
Leydig s cell
¶óÀ̵ðÈ÷¼¼Æ÷.
MCH => mean cell hemoglobin
Æò±ÕÀûÇ÷±¸Ç÷»ö¼Ò
MCHC => mean cell hemogiooln concentration
Æò±ÕÀûÇ÷±¸Ç÷»ö¼Ò³óµµ
MCV => mean cell volume
Æò±ÕÀûÇ÷±¸¿ëÀû
Merkel cell carcinoma
¸Þ¸£Ä̼¼Æ÷ ¾Ï(Á¾)
Mikulicz cell
¹ÌÄð¸®Áî ¼¼Æ÷
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
lupus erythematosus cell = LE cell
È«¹Ý¼º ·çǪ½º¼¼Æ÷(¡á¬øà)
neurolemmal cell [schwanns cell]
½Å°æÁý¼¼Æ÷
pale cell acanthoma => clear cell acanthoma
parafollicular cell [calcitonin cell]
¼ÒÆ÷°ç¼¼Æ÷
plasma cell orificial mucositis => plasma cell cheilitis
quiescent cell, Q cell
Á¤Áö¼¼Æ÷
secretory epithelial cell [glandular cell]
ºÐºñ»óÇǼ¼Æ÷ (»ù¼¼Æ÷)
supporting cell [sertoli cell]
¹öÆÀ¼¼Æ÷
supporting cell [type ii glomus cell]
¹öÆÀ¼¼Æ÷
sustentacular cell [sertoli cell]
¹öÆÀ¼¼Æ÷
abnormality of cell interaction
¼¼Æ÷»óÈ£ÀÛ¿ëÀÌ»ó
acantholytic cell
±Ø¼¼Æ÷ÇØ¸®¼¼Æ÷
acanthome a cellules claires => clear cell acanthoma
accessory cell
º¸Á¶¼¼Æ÷, ºÎ¼ö¼¼Æ÷
acidophilic cell
È£»ê¼º¼¼Æ÷
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½